论文部分内容阅读
[目的]分析肝肿瘤血管栓塞术后栓塞后综合征的相关因素及探讨防治措施。[方法]回顾性分析500例肝癌患者接受肿瘤动脉栓塞术后的栓塞后综合征发生情况。[结果]单因素分析显示两组年龄、性别、病情轻重、临床分期、肿瘤大小均相近,发生栓塞后综合征组手术时间、栓塞程度、术前紧张程度、栓塞剂中未加入利多卡因和地塞米松高于非发生栓塞综合征组(P﹤0.05)。多因素逐步Logistic回归分析显示术手术时间、栓塞程度、栓塞剂中是否加入利多卡因和地塞米松均为栓塞综合征危险因素。[结论]肝癌栓塞后栓塞综合征相关因素主要为手术时间、栓塞程度,在栓塞剂里加入利多卡因及地塞米松可降低发症的发生率。
[Objective] To analyze the related factors of post-embolization syndrome after hepatic tumor embolization and to discuss the prevention and cure measures. [Method] A retrospective analysis of 500 cases of liver cancer patients undergoing embolization of tumor after embolism syndrome. [Results] Univariate analysis showed that the age, gender, severity of illness, clinical stage and tumor size were similar in two groups. The postoperative time of embolization syndrome, the degree of embolization, the degree of preoperative embolism, the absence of lidocaine and Dexamethasone was higher than non-embolism syndrome group (P <0.05). Multi-factor Logistic regression analysis showed that operative time, degree of embolism, whether or not lidocaine was added to lidocaine and dexamethasone were risk factors for embolism syndrome. [Conclusion] The related factors of embolism syndrome after liver cancer embolization are mainly the operation time and the degree of embolism. The addition of lidocaine and dexamethasone to the embolization agent can reduce the incidence of complications.